Sunosi — CareFirst (Caremark)

Preferred products

• armodafinil
• modafinil

Initial criteria

• The requested drug is being prescribed by, or in consultation with, a sleep specialist.
• The diagnosis has been confirmed by sleep study.
• The patient meets ONE of the following:
• • The patient has experienced an inadequate treatment response to armodafinil OR modafinil.
• • The patient has experienced an intolerance to armodafinil OR modafinil.
• • The patient has a contraindication that would prohibit a trial of ALL of the following: armodafinil, modafinil.

Reauthorization criteria

• The patient has achieved or maintained a decrease in daytime sleepiness with narcolepsy from baseline.

Approval duration

12 months